Statin use and need for therapy in chronic lymphocytic leukemia

Impact of the host genetic background on prognosis of chronic lymphocytic leukemia

(2010) S. Rasi et al.   BLOOD

Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups

(2010) D A MacIntyre et al.   LEUKEMIA

Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia

(2010) Tait D. Shanafelt et al.   LEUKEMIA & LYMPHOMA

Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era

(2009) Grzegorz S. Nowakowski et al.   JOURNAL OF CLINICAL ONCOLOGY

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia

(2008) J B Weinberg et al.   LEUKEMIA

Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20

(2008) Magdalena Winiarska et al.   PLOS MEDICINE

Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway

(2007) Kwang Seok Ahn et al.   BIOCHEMICAL PHARMACOLOGY